Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).

@article{Buckler1999OvulationIW,
  title={Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).},
  author={Helen Buckler and Wm. Robertson and Anna Lisa Anderson and Madge Vickers and Ann Lambert},
  journal={Human reproduction},
  year={1999},
  volume={14 12},
  pages={2969-73}
}
We investigated whether a recombinant follicle stimulating hormone (FSH) (Puregon) can be administered less frequently and at lower doses during ovulation induction than is current practice. Patients (20-35 years, body mass index <30 kg/m(2)) with infertility and chronic anovulation secondary to polycystic ovarian syndrome and resistant to previous clomiphene treatment received (Puregon); 100 IU, n = 17 patients, or 50 IU, n = 10 patients) on alternate days. After 2 weeks and in the absence of… CONTINUE READING